NCT03925207

Brief Summary

Retrobulbar block is used to provide perioperative analgesia and anesthesia for orbital ball implants after enucleation surgery in the investigator's hospital. Retrobulbar block alone can provide quicker recovery, decreased time to discharge, opioid sparing, reduced costs. However, patients undergoing orbital ball implants after enucleation surgery with retrobulbar block alone suffered more preoperative and intraoperative anxiety,postoperative pain, and postoperative nausea and vomiting. General anesthesia alone is administered to patients undergoing orbital ball implants after enucleation surgery and opioids are used in adjunct with general anesthesia to suppress pain and hemodynamic stress associated with surgical trauma. GA only associated with more systemic opioids, short-term cognitive impairment, somnolence, and postoperative nausea and vomiting that can increase patient morbidity and delay discharge. Opioids, however, can result in adverse effects such as nausea and vomiting, pruritus, sedation. As a result of this growing demand of efficient and effective anesthesia management for orbital ball implants after enucleation surgery is becoming increasingly important. Numerous studies have reported benefits of an retrobulbar block for orbital ball implants after enucleation surgery, including quicker recovery and decreased time to discharge, decreased pain scores, opioid sparing, reduced costs, less intraoperative hemodynamic variability, improved patient satisfaction, and, in some cases, reduced GA- and/or opioid-related side effects. A recent systematic review examining all modes of postoperative pain management following orbital ball implants after enucleation surgery concluded that retrobulbar block are superior to all other forms of postoperative pain control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 24, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

June 28, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2020

Completed
Last Updated

December 19, 2020

Status Verified

December 1, 2020

Enrollment Period

6 months

First QC Date

February 26, 2019

Last Update Submit

December 16, 2020

Conditions

Keywords

retrobulbar blockgeneral anesthesia

Outcome Measures

Primary Outcomes (3)

  • postoperative pain upon arrival at and discharge from the postanesthesia care unit

    Visual Analogue Scale score(0-10, no pain - worse) of postoperative pain,

    through study completion: an average of 24 hour

  • analgesic consumption

    Dose of analgesic consumption

    through study completion: an average of 24 hours

  • rescue analgesia

    Rate of rescue analgesia

    through study completion, an average of 24 hours

Secondary Outcomes (1)

  • Postoperative nausea and vomiting

    through study completion, an average of 24 hours

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients were included if they underwent orbital ball implants after enucleation surgery by one ophthalmologist surgeon specializing in oculoplastic and orbital surgery at our centre above 18 years old

You may qualify if:

  • Patients were included if they underwent orbital ball implants after enucleation surgery by one ophthalmologist surgeon specializing in oculoplastic and orbital surgery at our centre.

You may not qualify if:

  • Patients were excluded if they underwent other concurrent surgical procedures, or were under 18 yr of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

叶伟娣

Hangzhou, China

Location

Weidi Ye

Hanzhou, China

Location

Study Officials

  • Zhiying Wu, Doctor

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2019

First Posted

April 24, 2019

Study Start

June 28, 2019

Primary Completion

December 28, 2019

Study Completion

July 18, 2020

Last Updated

December 19, 2020

Record last verified: 2020-12

Locations